To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Caixa Capital Risc divests Sanifit Therapeutics to Vifor Pharma
CriteriaCaixa's venture capital subsidiary Caixa Capital Risc has sold Sanifit Therapeutics to Vifor Pharma, a global pharmaceutical company.
